BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10677300)

  • 1. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations.
    Hundscheid RD; Sistermans EA; Thomas CM; Braat DD; Straatman H; Kiemeney LA; Oostra BA; Smits AP
    Am J Hum Genet; 2000 Feb; 66(2):413-8. PubMed ID: 10677300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of patterns of inheritance of premature ovarian failure syndrome carrying maternal and paternal premutations.
    Beke A; Piko H; Haltrich I; Karcagi V; Rigo J; Molnar MJ; Fekete G
    BMC Med Genet; 2018 Jul; 19(1):113. PubMed ID: 29986653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature ovarian failure is associated with maternally and paternally inherited premutation in Brazilian families with fragile X.
    Vianna-Morgante AM; Costa SS
    Am J Hum Genet; 2000 Jul; 67(1):254-5; author reply 256-8. PubMed ID: 10848496
    [No Abstract]   [Full Text] [Related]  

  • 4. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure.
    Hundscheid RD; Smits AP; Thomas CM; Kiemeney LA; Braat DD
    Am J Med Genet A; 2003 Feb; 117A(1):6-9. PubMed ID: 12548733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X chromosome inactivation does not define the development of premature ovarian failure in fragile X premutation carriers.
    Spath MA; Nillesen WN; Smits AP; Feuth TB; Braat DD; van Kessel AG; Yntema HG
    Am J Med Genet A; 2010 Feb; 152A(2):387-93. PubMed ID: 20101683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions.
    Mailick MR; Hong J; Greenberg J; Smith L; Sherman S
    Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):705-11. PubMed ID: 25346430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature ovarian failure and fragile X premutation: a study on 45 women.
    Bussani C; Papi L; Sestini R; Baldinotti F; Bucciantini S; Bruni V; Scarselli G
    Eur J Obstet Gynecol Reprod Biol; 2004 Feb; 112(2):189-91. PubMed ID: 14746957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry.
    Utine GE; Şimşek-Kiper PÖ; Akgün-Doğan Ö; Ürel-Demir G; Alanay Y; Aktaş D; Boduroğlu K; Tunçbilek E; Alikaşifoğlu M
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():76-80. PubMed ID: 29275276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X premutation screening in women with premature ovarian failure.
    Conway GS; Payne NN; Webb J; Murray A; Jacobs PA
    Hum Reprod; 1998 May; 13(5):1184-7. PubMed ID: 9647544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premature ovarian failure and the FMR1 gene.
    Murray A
    Semin Reprod Med; 2000; 18(1):59-66. PubMed ID: 11299521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers.
    Murray A; Ennis S; Morton N
    Am J Hum Genet; 2000 Jul; 67(1):253-4; author reply 256-8. PubMed ID: 10848495
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between idiopathic premature ovarian failure and fragile X premutation.
    Marozzi A; Vegetti W; Manfredini E; Tibiletti MG; Testa G; Crosignani PG; Ginelli E; Meneveri R; Dalprà L
    Hum Reprod; 2000 Jan; 15(1):197-202. PubMed ID: 10611212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of the FMR1 gene in menopause: study of 147 Spanish women.
    Mallolas J; Duran M; Sánchez A; Jiménez D; Castellví-Bel S; Rifé M; Milà M
    Menopause; 2001; 8(2):106-10. PubMed ID: 11256870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?
    Sherman SL
    Am J Hum Genet; 2000 Jul; 67(1):11-3. PubMed ID: 10848491
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives.
    Hundscheid RD; Braat DD; Kiemeney LA; Smits AP; Thomas CM
    Hum Reprod; 2001 Mar; 16(3):457-62. PubMed ID: 11228211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile X premutations are not a major cause of early menopause.
    Kenneson A; Cramer DW; Warren ST
    Am J Hum Genet; 1997 Dec; 61(6):1362-9. PubMed ID: 9399905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data.
    Uzielli ML; Guarducci S; Lapi E; Cecconi A; Ricci U; Ricotti G; Biondi C; Scarselli B; Vieri F; Scarnato P; Gori F; Sereni A
    Am J Med Genet; 1999 May; 84(3):300-3. PubMed ID: 10331612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers.
    Ennis S; Ward D; Murray A
    Eur J Hum Genet; 2006 Feb; 14(2):253-5. PubMed ID: 16251893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premature ovarian failure and FRAXA premutation: Positive correlation in a Brazilian survey.
    Machado-Ferreira Mdo C; Costa-Lima MA; Boy RT; Esteves GS; Pimentel MM
    Am J Med Genet A; 2004 Apr; 126A(3):237-40. PubMed ID: 15054835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and risk model development for menopausal age in fragile X premutation carriers.
    Spath MA; Feuth TB; Smits AP; Yntema HG; Braat DD; Thomas CM; van Kessel AG; Sherman SL; Allen EG
    Genet Med; 2011 Jul; 13(7):643-50. PubMed ID: 21597380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.